Leukemia, Myeloid, Acute: all 3,035 studies
Page 1 of 31. Open to participants first (746), then studies with results posted, then the rest; newest registration first within each.
- CARCIK CD123/33 for Refractory/Relapsed AML and BPDCN in Children and AdultsRecruitingNCT07877610Phase 1/2
- Mitoxantrone Hydrochloride Liposome Combined With Cladribine And Sotorasib For Relapsed Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07874737Phase 2
- This Study Aims to Improve the Stratification of Patients With Acute Myeloid Leukemia to Enable More Personalized and Effective Treatments, and to Identify and Functionally Validate, at the Single-cell Level, Biomarkers That Can Predict Response to Venetoclax.RecruitingNCT07874100Not applicable
- KATALYST-HEME-01: Study of the KAT6 Inhibitor MEN2312 in Heme MalignanciesNot yet recruitingNCT07873827Phase 1/2
- NAC for Hematopoietic Recovery in Low/Intermediate-Risk AML After CR: A Randomized Controlled StudyNot yet recruitingNCT07869342Not applicable
- Feasibility and Efficiency Study for the Implementation of a New Screening Method for Patients With Acute Myeloid Leukemia, in Laboratory PracticeNot yet recruitingNCT07867704Not applicable
- Phase II De-Escalation Study of Metronomic Decitabine/Cedazuridine Plus Venetoclax in AMLNot yet recruitingNCT07867626Phase 2
- Testing the Investigational Medication Combination of Azacitidine, Venetoclax, and Quizartinib Compared to the Usual Treatment of Cytarabine, Daunorubicin, and Quizartinib for Patients With FLT3-ITD Mutant Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)Not yet recruitingNCT07862517Phase 2
- CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07841002Phase 1
- Liposomal Mitoxantrone Plus Azacitidine and Venetoclax in Newly Diagnosed Elderly or Unfit AMLNot yet recruitingNCT07828535Phase 1
- Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic SyndromeNot yet recruitingNCT07819396Phase 2
- Hydrochloroquinine & Decitabine With Venetoclax in AMLNot yet recruitingNCT07814339Phase 1
- Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy FailureEnrolling by invitationNCT07813390Phase 2
- Prognostic Value of CAR, AFR and Ferritin in Non-M3 AMLNot yet recruitingNCT07810829
- Prevention of Oral Mucositis in Adults in With Hematologic MalignancyNot yet recruitingNCT07809984Not applicable
- Efficacy of a Smart Holistic Health Care Platform Intervention on Cancer Children and Parents' Bio-Psycho-Social and Spiritual HealthRecruitingNCT07805096Not applicable
- Home-based Intravenous Cytarabine Treatment for Acute Myeloid Leukemia: a National Danish Study of Feasibility, Costs, and ImplementationNot yet recruitingNCT07802015
- A Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic MalignanciesEnrolling by invitationNCT07784309Phase 1
- Venetoclax, Chidamide, and Chiglitazar Sodium (VCC) in Patients With Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT07783100Phase 2
- Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic SyndromeNot yet recruitingNCT07780565Phase 1
- Improving Delivery of Aging-Related Supportive Care for Older Adults With Acute Myeloid LeukemiaNot yet recruitingNCT07777471Not applicable
- A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)RecruitingNCT07771803Early Phase 1
- A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic LeukemiaNot yet recruitingNCT07770698Phase 1/2
- Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia PatientsRecruitingNCT07763054
- A Study of VABu Conditioning Regimen in Allo-HSCT for AML PatientsNot yet recruitingNCT07762508Not applicable
- Umbilical Cord Blood Consolidation for Older Adults With Intermediate- and High-Risk AMLNot yet recruitingNCT07761702Phase 3
- PBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDSRecruitingNCT07761533Phase 1/2
- Allogeneic iNKT Cell Therapy (agenT-797) After SCTNot yet recruitingNCT07758218Phase 1
- Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine, Sequentially Followed by HSCT for R/R AML.Not yet recruitingNCT07757672Phase 1/2
- Gilteritinib-Azacitidine-Venetoclax Combination Therapy in Patients With Relapsed/Refractory LeukemiaNot yet recruitingNCT07755202Phase 2
- A Randomized Trial of Venetoclax-Based Induction Intensity in Newly Diagnosed Acute Myeloid LeukemiaNot yet recruitingNCT07754799Phase 2
- A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AMLRecruitingNCT07751991Phase 1
- Plasma ctDNA Monitoring in Pediatric Acute LeukemiaNot yet recruitingNCT07751588
- GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid TumorsNot yet recruitingNCT07749976Phase 1/2
- HMA-Venetoclax Induction in Newly Diagnosed AMLNot yet recruitingNCT07748455Phase 2
- A Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid LeukemiaRecruitingNCT07743112Phase 2
- Harnessing the Immunosuppressive Leukemic Microenvironment to Engineer T Cells With Enhanced Anti-tumor FunctionalityNot yet recruitingNCT07743047
- Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic SyndromeNot yet recruitingNCT07737769Phase 1
- Geriatric Assessment-Guided Treatment Selection in Older Adults With Acute Myeloid LeukemiaNot yet recruitingNCT07735208Phase 2
- Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AMLNot yet recruitingNCT07735117Phase 3
- Venetoclax in Association With 3+7 and Midostaurin in FLT3-mutated Acute Myeloid LeukemiaNot yet recruitingNCT07726576Phase 1/2
- Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AMLRecruitingNCT07723703Phase 1
- A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML PatientsNot yet recruitingNCT07722767Phase 1
- S243249 Monotherapy in Patients With Relapsed or Refractory Acute Leukemia With a KMT2A or NUP98 Translocation or Relapsed or Refractory AML With NPM1c MutationNot yet recruitingNCT07722312Phase 1/2
- A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid MalignanciesNot yet recruitingNCT07719348Phase 1/2
- PRAISE-IR Versus CIBMTR ControlsNot yet recruitingNCT07717164
- DEC3-VEN vs. Venetoclax-Based vs. DA Regimens in Newly Diagnosed AMLRecruitingNCT07712848Phase 3
- Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic MalignanciesNot yet recruitingNCT07710781Not applicable
- Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPNRecruitingNCT07710534Phase 2
- Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute LeukemiaNot yet recruitingNCT07696481Early Phase 1
- Lisaftoclax Plus Azacitidine Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients at High Risk of RelapseNot yet recruitingNCT07686965Phase 3
- Trial of Revumenib Plus FLA Chemotherapy for Children With Relapsed or Refractory NUP98-rearranged AML."Not yet recruitingNCT07686107Phase 2
- Caris Chromoseq Data CollectionRecruitingNCT07680868
- A Clinical Study to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell Injection Targeting CD33/CD70 in Adult Patients With Relapsed/Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07676006Early Phase 1
- VA Consolidation in Intermediate-Risk AMLRecruitingNCT07672262Phase 2
- Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and PrognosisRecruitingNCT07670130
- Anti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT07668557Phase 1
- Study on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 MutationsNot yet recruitingNCT07664839Phase 2
- Luspatercept for CIA in AMLRecruitingNCT07663864Phase 1/2
- A Study of CRD3874-SI in People With LeukemiaRecruitingNCT07661095Phase 1
- Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive ChemotherapyEnrolling by invitationNCT07651176Phase 2/3
- Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive ChemotherapyEnrolling by invitationNCT07651163Phase 2/3
- FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid LeukemiaRecruitingNCT07645469Phase 1
- Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete RemissionNot yet recruitingNCT07644481Not applicable
- Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AMLNot yet recruitingNCT07643636Phase 2
- VA-CAG Two-Week vs. Three-Week Regimen for Induction Remission in Newly Diagnosed Acute Myeloid Leukemia.Not yet recruitingNCT07642453Phase 2
- Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell TransplantNot yet recruitingNCT07634536Phase 2
- Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition.RecruitingNCT07627568
- A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory NPM1-Mutated Acute Myeloid LeukemiaRecruitingNCT07623616Phase 2
- A Study to Assess How Well the Study Medicine IPN60340 Works in Combination With Azacitidine and Venetoclax, Compared to Placebo in Combination With Azacitidine and Venetoclax, in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Cannot Receive Intensive ChemotherapyNot yet recruitingNCT07623187Phase 2/3
- ATRN-119 in Combination With Decitabine in Patients With TP53-Mutated AML or Higher-Risk MDSNot yet recruitingNCT07617363Phase 1
- A Home-Based Exercise Intervention (CAREFit-BMT) in Improving Heart Function Among Patients With High Risk Acute Myeloid Leukemia Undergoing Stem Cell TransplantRecruitingNCT07616921Not applicable
- Phase I Study of FXS0683 in the Treatment of Blood TumorsRecruitingNCT07616089Phase 1
- Individualized AML TreatmentRecruitingNCT07613385
- Ivosidenib as Maintenance Therapy in Transplant-Ineligible IDH1-mutated AML and HR-MDSRecruitingNCT07607418Phase 2
- Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)Enrolling by invitationNCT07607327
- Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AMLNot yet recruitingNCT07605949Phase 2
- FLUDARABINE-TREOSULFAN REDUCED INTENSITY CONDITIONING REGIMEN PRIOR HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST TRANSPLANTATION CYCLOPHOSPHAMIDE FOR OLDER AND/OR FRAIL PATIENTS WITH AMLNot yet recruitingNCT07598110Phase 2
- Digital Patient-Reported Assessment in Older Adults With Acute LeukemiaNot yet recruitingNCT07597590Not applicable
- Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCTRecruitingNCT07591649Phase 1/2
- Haplo-Cord HSCT for AML/MDSRecruitingNCT07588360Not applicable
- Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic MalignanciesRecruitingNCT07584889Phase 1/2
- VABu Conditioning in Elderly AML HSCTRecruitingNCT07583888Phase 2/3
- BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 MutationNot yet recruitingNCT07583303Phase 1
- Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic SyndromeRecruitingNCT07582172Phase 2
- A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)RecruitingNCT07581002Phase 2/3
- SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDSNot yet recruitingNCT07575412Phase 2
- Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell TransplantationRecruitingNCT07573111Phase 1
- A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic TransplantNot yet recruitingNCT07572929Phase 2
- Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AMLNot yet recruitingNCT07572695
- Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell TransplantationRecruitingNCT07570407
- Use of Electrical Bioimpedance in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients (Bioimpedance)Not yet recruitingNCT07570056
- Cord Blood Transplantation in Children and Young Adults With Blood CancerRecruitingNCT07566377Phase 2
- Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic MalignanciesRecruitingNCT07565220Phase 1
- TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete RemissionNot yet recruitingNCT07563920Not applicable
- Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT07563179Phase 2
- Menin-Inhibitor Targeted Maintenance in AMLNot yet recruitingNCT07563010Phase 2
- SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDSNot yet recruitingNCT07562568Phase 2
- Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ± Silibinin in Treating Newly Diagnosed AML (Non-M3).RecruitingNCT07561892Phase 4
- Matched Sibling Allogenic Stem Cell Transplantation With Adoptive Immunotherapy With Regulatory And Conventional T Cells For High Risk Acute Myeloid LeukemiaNot yet recruitingNCT07552649Phase 2